跳至主要内容
临床试验/NCT00954668
NCT00954668撤回不适用

ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI)

University of Leipzig2 个研究点 分布在 1 个国家开始时间: 2009年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Death and non-fatal recurrent infarction

研究概览

简要总结

Of estimated 140,000 cases of acute myocardial infarction admitted to hospitals in Germany per year, approximately 50% present with Non-ST-elevation myocardial infarction (NSTEMI). The currently available evidence led to current guideline recommendations that a systematic approach of immediate angiography in NSTEMI patients stabilized with contemporary antiplatelet treatment is not mandatory. However, this immediate invasive approach is appealing because it allows treating the underlying cause (the plaque rupture) as early as possible with subsequent reduction of death and recurrent myocardial infarction. In the IDEAL NSTEMI trial we test an immediate invasive approach (<2 h) with an approach 12-72 h according top guidelines with respect to 6 months death and mortality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • NSTEMI with
  • ischemic symptoms >10 minutes within 24 h
  • elevated troponin or creatine kinase above the upper limit of normal
  • ST-segment depression or transient ST-segment elevation, T-wave inversion
  • informed consent.

排除标准

  • Age < 18 years
  • Age > 90 years
  • persistent angina
  • hemodynamic instability
  • overt congestive heart failure
  • life-threatening arrhythmias
  • limited life-expectancy < 6 months
  • chronic oral anticoagulation
  • fibrinolysis < 48 hours
  • PCI < 14 days
  • contraindication for treatment with glycoprotein IIb/IIIa inhibitors, heparin, aspirin and clopidogrel
  • recent major trauma or surgery

研究组 & 干预措施

immediate angiography

Experimental

Immediate invasive angiography < 2 h after randomization

干预措施: immediate angiography and revascularization (Procedure)

early invasive angiography

Active Comparator

early invasive angiography 12-72 h after randomization

干预措施: early invasive angiography (Procedure)

结局指标

主要结局

Death and non-fatal recurrent infarction

时间窗: 6 months

次要结局

  • Composite of death, recurrent non-fatal myocardial infarction, refractory ischemia or target vessel re-vascularization(6 months)

研究者

发起方
University of Leipzig
申办方类型
Other
责任方
Principal Investigator
主要研究者

Holger Thiele

Clinical Professor Prof. Dr. Holger Thiele

University of Leipzig

研究点 (2)

Loading locations...

相似试验